keyword
https://read.qxmd.com/read/38647687/osteoid-osteoma-appearing-after-bony-fracture-in-a-girl-with-osteogenesis-imperfecta
#21
JOURNAL ARTICLE
Kei Sakamoto, Osamu Miyazaki, Ayako Imai, Reiko Okamoto, Yoshiyuki Tsutsumi, Mikiko Miyasaka, Atsuhito Seki, Takako Yoshioka, Shunsuke Nosaka
Osteoid osteoma (OO) is a common, benign bone tumor. However, there are no case reports of OO associated with osteogenesis imperfecta (OI), or pathological fractures in OO. A 3-year-old girl with OI sustained a complete right tibial diaphyseal fracture. Bony fusion was completed after 4 months of conservative therapy; nevertheless, 18 months later spontaneous pain appeared at the fracture site, without any cause. Plain radiographs showed a newly apparent, rounded area of translucency 1 cm in diameter, just overlapping the previous fracture...
April 22, 2024: Skeletal Radiology
https://read.qxmd.com/read/38647678/bortezomib-elevates-intracellular-free-fe-2-by-enhancing-ncoa4-mediated-ferritinophagy-and-synergizes-with-rsl-3-to-inhibit-multiple-myeloma-cells
#22
JOURNAL ARTICLE
Yanyan Zhang, Fen He, Wei Hu, Jingqi Sun, Hongyan Zhao, Yuzhi Cheng, Zhanyou Tang, Jiarui He, Xiangyuan Wang, Tairan Liu, Cong Luo, Zhongwei Lu, Mei Xiang, Yiting Liao, Yihao Wang, Junjun Li, Jiliang Xia
Iron contributes to tumor initiation and progression; however, excessive intracellular free Fe2+ can be toxic to cancer cells. Our findings confirmed that multiple myeloma (MM) cells exhibited elevated intracellular iron levels and increased ferritin, a key protein for iron storage, compared with normal cells. Interestingly, Bortezomib (BTZ) was found to trigger ferritin degradation, increase free intracellular Fe2+ , and promote ferroptosis in MM cells. Subsequent mechanistic investigation revealed that BTZ effectively increased NCOA4 levels by preventing proteasomal degradation in MM cells...
April 22, 2024: Annals of Hematology
https://read.qxmd.com/read/38647671/enhancing-surgical-outcomes-accurate-identification-and-removal-of-prostate-cancer-with-b7-h3-targeted-nir-ii-molecular-imaging
#23
JOURNAL ARTICLE
Yaqi Tian, Hongliang Shen, Lingbing Li, Xiaohua Jia, Jin Liu, Zhenhua Hu, Liang Wang, Jie Tian
PURPOSE: One of the main reasons for prostate cancer (PCa) recurrence is the difficulty in identifying and removing cancerous lesions during surgery. Accurately localizing and excising cancerous tissue remains a significant challenge. The second near-infrared window (NIR-II, 1000-1700 nm) fluorescence offers enhanced resolution, a high signal-to-noise ratio, and the potential for deeper tissue penetration. However, this technology is not currently employed for intraoperative imaging of PCa...
April 22, 2024: European Journal of Nuclear Medicine and Molecular Imaging
https://read.qxmd.com/read/38647670/reasons-why-the-idea-that-radiation-exposures-induce-cancer-needs-to-be-revisited
#24
JOURNAL ARTICLE
Nori Nakamura
PURPOSE: It has long been thought that the carcinogenic effect of radiation resulted from the induction of oncogenic mutations which then led to an increase in the proportion of cancer-bearing individuals. However, even as early as the 1960s, there were indications that the carcinogenic effect of radiation might result from the induction of an earlier onset of cancer. Recently, the former notion was challenged by its inability to explain time-dependent decline of the relative risk following an exposure to radiation, and a parallel shift of mouse survival curves toward younger ages following an exposure to radiation...
April 22, 2024: International Journal of Radiation Biology
https://read.qxmd.com/read/38647666/-cochlear-implantation-in-patients-with-autoimmune-hearing-loss
#25
JOURNAL ARTICLE
Maximilian Armstorfer, Lennart Weitgasser, Stefan Tschani, Sebastian Rösch
BACKGROUND: Autoimmune inner ear disease (AIED) manifests with recurrent fluctuating sensorineural hearing loss and vestibular symptoms. Treatment includes steroids and a variety of immunosuppressants. Despite adequate treatment, sensorineural hearing loss can be progressive to the point of deafness. In these patients, a cochlear implant (CI) is indicated. We present the case of a 25-year-old male who underwent cochlear implantation in the left ear. After implantation we noticed brisk variations in impedances which were related to application of the previously prescribed tumor necrosis alpha (TNFα) inhibitor adalimumab...
April 22, 2024: HNO
https://read.qxmd.com/read/38647665/-to-implant-or-not-to-implant-electrically-evoked-auditory-brainstem-response-audiometry-for-decision-making-in-vestibular-schwannoma-resection-with-ci
#26
REVIEW
Valerie Dahm, Anselm Joseph Gadenstaetter, Christoph Arnoldner
Vestibular schwannomas (VS) are often associated with debilitating hearing loss. Therefore, preservation and rehabilitation of hearing have become major therapeutic goals of VS management. Recently, cochlear implantation (CI) has been established as an effective treatment option for VS-associated hearing loss. Nevertheless, the integrity and proper function of the cochlear nerve must be evaluated before conducting CI to ensure optimal CI outcomes. Various methods to determine cochlear nerve integrity and functionality have emerged in the last few years...
April 22, 2024: HNO
https://read.qxmd.com/read/38647662/proceedings-of-the-first-global-meeting-of-the-posterior-fossa-society-state-of-the-art-in-cerebellar-mutism-syndrome
#27
JOURNAL ARTICLE
Karin S Walsh, Barry Pizer, Sharyl Samargia-Grivette, Andrew L Lux, Jeremy D Schmahmann, Helen Hartley, Shivaram Avula
PURPOSE: The Posterior Fossa Society, an international multidisciplinary group, hosted its first global meeting designed to share the current state of the evidence across the multidisciplinary elements of pediatric post-operative cerebellar mutism syndrome (pCMS). The agenda included keynote talks from world-leading speakers, compelling abstract presentations and engaging discussions led by members of the PFS special interest groups. METHODS: This paper is a synopsis of the first global meeting, a 3-day program held in Liverpool, England, UK, in September 2022...
April 22, 2024: Child's Nervous System: ChNS: Official Journal of the International Society for Pediatric Neurosurgery
https://read.qxmd.com/read/38647660/diagnostic-support-in-pediatric-craniopharyngioma-using-deep-learning
#28
JOURNAL ARTICLE
Giovanni Castiglioni, Joaquín Vallejos, Jhon Intriago, María Isabel Hernández, Samuel Valenzuela, José Fernández, Ignacio Castro, Sergio Valenzuela, Pablo A Estévez, Cecilia Okuma
PURPOSE: We studied a pediatric group of patients with sellar-suprasellar tumors, aiming to develop a convolutional deep learning algorithm for radiological assistance to classify them into their respective cohort. METHODS: T1w and T2w preoperative magnetic resonance images of 226 Chilean patients were collected at the Institute of Neurosurgery Dr. Alfonso Asenjo (INCA), which were divided into three classes: healthy control (68 subjects), craniopharyngioma (58 subjects) and differential sellar/suprasellar tumors (100 subjects)...
April 22, 2024: Child's Nervous System: ChNS: Official Journal of the International Society for Pediatric Neurosurgery
https://read.qxmd.com/read/38647653/preparation-of-liposome-gel-by-calcium-cross-linking-induces-the-long-term-release-of-dox-to-improve-the-antitumor-effect
#29
JOURNAL ARTICLE
Long Wang, Yi Wang, Zixuan Ye, Yitong Yu, Cheng Wang, Lin Qiu, Xuancheng Du, Shuwen Zhou, Jianhao Wang, Pengju Jiang
Doxorubicin (DOX) is one of the most commonly used anticancer drugs; however, its clinical application is greatly limited due to its toxicity and chemotherapy resistance. The delivery of DOX by liposomes (Lipos) can improve the blood circulation time in vivo and reduce toxic side effects, but the drug's accumulation in the tumor is often insufficient for effective treatment. In this study, we present a calcium cross-linked liposome gel for the encapsulation of DOX, demonstrating its superior long-term release capabilities compared to conventional Lipos...
April 22, 2024: Molecular Pharmaceutics
https://read.qxmd.com/read/38647646/screening-and-surveillance-recommendations-for-central-nervous-system-hemangioblastomas-in-pediatric-patients-with-von-hippel-lindau-disease
#30
JOURNAL ARTICLE
Anna Laura Knoblauch, B-I Blaß, C Steiert, N Neidert, A Puzik, E Neumann-Haefelin, A Ganner, F Kotsis, T Schäfer, H P H Neumann, S Elsheikh, J Beck, J-H Klingler
PURPOSE: Von Hippel-Lindau (VHL) disease is an autosomal-dominantly inherited tumor predisposition syndrome. One of the most common tumors are central nervous system (CNS) hemangioblastomas. Recommendations on the initiation and continuation of the screening and surveillance program for CNS tumors in pediatric VHL patients are based on small case series and thus low evidence level. To derive more robust screening recommendations, we report on the largest monocentric pediatric cohort of VHL patients...
April 22, 2024: Journal of Neuro-oncology
https://read.qxmd.com/read/38647603/epidural-angioleiomyoma-an-extraordinary-cause-of-compressive-myelopathy-mri-findings-with-histopathological-correlation
#31
JOURNAL ARTICLE
Carlos Jiménez Mascuñán, Alberto Martínez Martínez, Rosa Ríos Pelegrina, Antonio Jesús Láinez Ramos-Bossini
BACKGROUND: Angioleiomyomas are benign mesenchymal tumors usually located in the limbs, with anecdotal reports in the spine. We present an atypical case of an epidural spine angioleiomyoma presenting with compressive myelopathy symptoms. The diagnosis was suggested based on MRI findings, and subsequently confirmed histopathologically. RESULTS: This is the first known occurrence of pure spinal epidural angioleiomyoma as a source of compressive myelopathy. The imaging presentation, especially the 'dark reticular sign' on MRI, was crucial in suggesting the diagnosis despite the atypical location CONCLUSION: This report serves to raise awareness among clinicians and radiologists about including angioleiomyoma in differential diagnoses for spinal epidural lesions with indicative MRI features...
April 22, 2024: European Spine Journal
https://read.qxmd.com/read/38647571/promising-anticancer-activity-of-cromolyn-in-colon-cancer-in-vitro-and-in-vivo-analysis
#32
JOURNAL ARTICLE
Amin Aliabadi, Mohammad Reza Haghshenas, Razie Kiani, Mohammad Reza Panjehshahin, Nasrollah Erfani
PURPOSE: Colon cancer is a prevalent cancer globally, representing approximately 10% of all cancer cases and accounting for 10% of all cancer-related deaths. Therefore, finding new therapeutic methods with high efficiency will be very valuable. Cromolyn (C), a common anti-allergic and mast cell membrane stabilizing drug, has recently shown valuable anti-cancer effects in several studies. This study was designed to investigate the anti-cancer activity of cromolyn on colon cancer in vitro and in vivo and to determine values such as selectivity index and survival effect...
April 22, 2024: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/38647548/systemic-inflammation-and-delirium-during-critical-illness
#33
JOURNAL ARTICLE
Nathan E Brummel, Christopher G Hughes, J Brennan McNeil, Pratik P Pandharipande, Jennifer L Thompson, Onur M Orun, Rameela Raman, Lorraine B Ware, Gordon R Bernard, Fiona E Harrison, E Wesley Ely, Timothy D Girard
PURPOSE: The purpose of this study was to determine associations between markers of inflammation and endogenous anticoagulant activity with delirium and coma during critical illness. METHODS: In this prospective cohort study, we enrolled adults with respiratory failure and/or shock treated in medical or surgical intensive care units (ICUs) at 5 centers. Twice per day in the ICU, and daily thereafter, we assessed mental status using the Richmond Agitation Sedation Scale (RASS) and the Confusion Assessment Method-Intensive Care Unit (CAM-ICU)...
April 22, 2024: Intensive Care Medicine
https://read.qxmd.com/read/38647531/a-selective-fibroblast-growth-factor-receptor-1-2-protac-degrader-with-antitumor-activity
#34
JOURNAL ARTICLE
Ying Kong, Xinyue Zhao, Zhaofu Wang, Siqi Yuan, Sheng Chen, Shidi Lou, Shichao Ma, Yunfeng Li, Xinghao Wang, Yangfeng Ge, Guobin Li, Hongbing Yang, Mengxi Zhao, Dandan Li, Hailong Zhang, Wenfu Tan, Juan Wang
The aberrant activation of fibroblast growth factor receptor (FGFR) acts as a potent driver of multiple types of human cancers. Despite the development of several conventional small-molecular FGFR inhibitors, their clinical efficacy is largely compromised due to low selectivity and side effects. Here, we report the selective FGFR1/2-targeting proteolysis targeting chimeric (PROTAC), BR-cpd7 that displays significant isoform specificity to FGFR1/2 with DC50 values around 10 nM, while sparing FGFR3. The following mechanistic investigation reveals the reduced FGFR signaling, through which BR-cpd7 induces cell cycle arrest and consequently blocks the proliferation of multiple FGFR1/2-dependent tumor cells...
April 22, 2024: Molecular Cancer Therapeutics
https://read.qxmd.com/read/38647528/a-bispecific-antibody-that-targets-the-membrane-proximal-region-of-mesothelin-and-retains-high-anticancer-activity-in-the-presence-of-shed-mesothelin
#35
JOURNAL ARTICLE
Anirban Chakraborty, Masanori Onda, Tara O'Shea, Junxia Wei, Xiufen Liu, Tapan K Bera, Ira Pastan
Mesothelin (MSLN) is a cell-surface protein that is expressed on many cancers, which makes it a popular target for antibody-based cancer therapy. However, MSLN is shed from cancer cells at high levels via proteases that cleave at its membrane-proximal C-terminal region. Shed MSLN accumulates in patient fluids and tumors and can block antibody-based MSLN-targeting drugs from killing cancer cells. A previously established monoclonal antibody (mAb), 15B6, binds MSLN at its protease-sensitive C-terminal region and does not bind shed MSLN...
April 22, 2024: Molecular Cancer Therapeutics
https://read.qxmd.com/read/38647488/free-radicals-generated-in-perfluorocarbon-water-liquid-liquid-interfacial-contact-electrification-and-their-application-in-cancer-therapy
#36
JOURNAL ARTICLE
Haimei Li, Zichen Wang, Xu Chu, Yi Zhao, Guangqin He, Yulin Hu, Yi Liu, Zhong Lin Wang, Peng Jiang
Electron transfer during solid-liquid contact electrification has been demonstrated to produce reactive oxygen species (ROS) such as hydroxyl radicals (• OH) and superoxide anion radicals (• O2 - ). Here, we show that such a process also occurs in liquid-liquid contact electrification. By preparing perfluorocarbon nanoemulsions to construct a perfluorocarbon-water "liquid-liquid" interface, we confirmed that electrons were transferred from water to perfluorocarbon in ultrasonication-induced high-frequency liquid-liquid contact to produce • OH and • O2 - ...
April 22, 2024: Journal of the American Chemical Society
https://read.qxmd.com/read/38647426/congenital-gastric-teratoma-presenting-with-gastrointestinal-bleeding-case-report-and-review-of-literature
#37
JOURNAL ARTICLE
Khadiga M Ali, Gena Abdel-Azeem, Tarik Barakat, Sherine M Elzeiny, Mohammed Albishbishy, Ahmed Megahed
BACKGROUND: Gastric teratoma is an extremely rare tumor, representing <1% of all pediatric teratomas, and commonly manifests as a palpable abdominal mass. Upper gastrointestinal tract bleeding in newborns and infants is rare and is mostly caused by a benign lesion. CASE REPORT: We present a 3-month-old boy who presented with recurrent attacks of hematemesis, vomiting, and melena which on work up revealed a gastric teratoma. DISCUSSION/CONCLUSION: Owing to the unique characteristics and the extreme rarity of this entity, accurate preoperative diagnosis has remained elusive...
April 22, 2024: Fetal and Pediatric Pathology
https://read.qxmd.com/read/38647420/-cicada-out-of-the-shell-deep-penetration-and-blockage-of-the-hsp90-pathway-by-ros-responsive-supramolecular-gels-to-augment-trimodal-synergistic-therapy
#38
JOURNAL ARTICLE
Fashun Li, Jianqin Yan, Chen Wei, Yi Zhao, Xiaowen Tang, Long Xu, Bin He, Yong Sun, Jing Chang, Yan Liang
Deep penetration and downregulation of heat shock protein (HSP) expression in multimodal synergistic therapy are promising approaches for curing cancer in clinical trials. However, free small-molecule drugs and most drug vehicles have a low delivery efficiency deep into the tumor owing to poor drug penetration and hypoxic conditions at the tumor site. In this study, the objective is to use reactive oxygen species (ROS)-responsive supramolecular gels co-loaded with the photosensitizer Zn(II) phthalocyanine tetrasulfonic acid (ZnPCS4 ) and functionalized tetrahedral DNA (TGSAs) (G@P/TGSAs) to enhance deep tissue and cell penetration and block the HSP90 pathway for chemo- photodynamic therapy (PDT) - photothermal therapy (PTT) trimodal synergistic therapy...
April 22, 2024: Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
https://read.qxmd.com/read/38647396/multifunctional-fluoropolymer-engineered-magnetic-nanoparticles-to-facilitate-blood-brain-barrier-penetration-and-effective-gene-silencing-in-medulloblastoma
#39
JOURNAL ARTICLE
Helen Forgham, Jiayuan Zhu, Xumin Huang, Cheng Zhang, Heather Biggs, Liwei Liu, Yi Cheng Wang, Nicholas Fletcher, James Humphries, Gary Cowin, Karine Mardon, Maria Kavallaris, Kristofer Thurecht, Thomas P Davis, Ruirui Qiao
Patients with brain cancers including medulloblastoma lack treatments that are effective long-term and without side effects. In this study, a multifunctional fluoropolymer-engineered iron oxide nanoparticle gene-therapeutic platform is presented to overcome these challenges. The fluoropolymers are designed and synthesized to incorporate various properties including robust anchoring moieties for efficient surface coating, cationic components to facilitate short interference RNA (siRNA) binding, and a fluorinated tail to ensure stability in serum...
April 22, 2024: Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
https://read.qxmd.com/read/38647377/drosha-regulates-mesenchymal-gene-expression-in-wilms-tumor
#40
JOURNAL ARTICLE
Patricia D B Tiburcio, Kavita Desai, Jiwoong Kim, Qinbo Zhou, Lei Guo, Xue Xiao, Li Zhou, Aysen Yuksel, Daniel R Catchpoole, James F Amatruda, Lin Xu, Kenneth S Chen
Wilms tumor, the most common pediatric kidney cancer, resembles embryonic renal progenitors. Currently, there are no ways to therapeutically target Wilms tumor driver mutations, such as in the microRNA processing gene DROSHA. Here we used a "multi-omics" approach to define the effects of DROSHA mutation in Wilms tumor. We categorized Wilms tumor mutations into four mutational subclasses with unique transcriptional effects: microRNA processing, MYCN activation, chromatin remodeling, and kidney developmental factors...
April 22, 2024: Molecular Cancer Research: MCR
keyword
keyword
66516
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.